Pureun-Haneul Lee

Pureun-Haneul Lee

Auto-generated profile, based on publicly available information

Pureun-Haneul Lee

Department of Internal Medicine, Soonchunhyang University Bucheon Hospital, Bucheon, Korea

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2021 in Allergy, Asthma & Immunology Research
Verified
Journal Article
Open access
PDF file
PLPureun-Haneul Lee
Pureun-Haneul Lee
SPShinhee Park
Shinhee Park
YLYun-Gi Lee
Yun-Gi Lee
SCSeon-Muk Choi
Seon-Muk Choi
MAMin-Hyeok An
Min-Hyeok An
AJAn-Soo Jang
An-Soo Jang
Lee PH, et al. Allergy Asthma Immunol Res. 2021 Nov;13(6):850-862. https://doi.org/10.4168/aair.2021.13.6.850

1 January 2020 in Journal of Korean Medical Science
Verified
Journal Article
Open access
PDF file
YLYun-Gi Lee
Yun-Gi Lee
JHJisu Hong
Jisu Hong
PLPureun-Haneul Lee
Pureun-Haneul Lee
JLJunehyuk Lee
Junehyuk Lee
SPSung-Woo Park
Sung-Woo Park
AJAn-Soo Jang
An-Soo Jang
Lee YG, et al. J Korean Med Sci. 2020 Sep;35(43):e362. https://doi.org/10.3346/jkms.2020.35.e362

1 January 2018 in Allergy, Asthma & Immunology Research
Verified
Journal Article
Open access
PDF file
BKByeong-Gon Kim
Byeong-Gon Kim
PLPureun-Haneul Lee
Pureun-Haneul Lee
SLSun-Hye Lee
Sun-Hye Lee
ABAe-Rin Baek
Ae-Rin Baek
JPJong-Sook Park
Jong-Sook Park
AJAn-Soo Jang
An-Soo Jang
Kim BG, et al. Allergy Asthma Immunol Res. 2018 Sep;10(5):533-542. https://doi.org/10.4168/aair.2018.10.5.533

1 October 2021 in International Journal of Chronic Obstructive Pulmonary Disease
Verified
Journal Article
Open access
PDF file
SPShinhee Park
Shinhee Park
PLPureun-Haneul Lee
Pureun-Haneul Lee
ABAe-Rin Baek
Ae-Rin Baek
JPJong-Sook Park
Jong-Sook Park
JLJunehyuk Lee
Junehyuk Lee
AJAn-Soo Jang
An-Soo Jang
Purpose: Chronic obstructive pulmonary disease (COPD) imposes a major healthcare burden. A tight junction protein, claudin-4 (CLDN4), may play a protective role in acute lung injury, but its role in COPD is unclear. To investigate the relationship between CLDN4 and COPD, we evaluated the association of CLDN4 with the clinical parameters of COPD, including exacerbations. Patients and Methods: We analyzed a cohort of 30 patients with COPD and 25 healthy controls and evaluated their clinical parameters, including lung function. The plasma CLDN4 level in stable and exacerbated COPD was measured. Results: The COPD patients were all males and predominantly smokers; their initial lung function was poorer than the healthy controls. The mean CLDN4 plasma level was 0.0219 ± 0.0205 ng/mg in the control group, 0.0086 ± 0.0158 ng/mg in the stable COPD group (COPD-ST) and 0.0917 ± 0.0871 ng/mg in the exacerbated COPD (COPD-EXA) group. The plasma CLDN4 level was significantly lower in the COPD-ST than the control group, but was significantly elevated in the COPD-EXA group. The plasma CLDN4 level was inversely correlated with forced vital capacity and forced expiratory volume in 1 second in the COPD-EXA group (r=0.506, P=0.001 and r=0.527, P< 0.001, respectively). Conclusion: The plasma CLDN4 level is closely correlated with COPD exacerbations and decreased lung function. This suggests that CLDN4 has potential as a severity marker for COPD.

24 August 2022 in Advances in Clinical and Experimental Medicine
Verified
Journal Article
Open access
MAMin-Hyeok An
Min-Hyeok An
SCSeon-Muk Choi
Seon-Muk Choi
PLPureun-Haneul Lee
Pureun-Haneul Lee
SPShinhee Park
Shinhee Park
ABAe-Rin Baek
Ae-Rin Baek
AJAn-Soo Jang
An-Soo Jang
Air pollutants exacerbate chronic airway diseases, such as asthma and chronic obstructive pulmonary disease (COPD). However, the underlying mechanisms are yet to be determined. While a number of studies have reported adverse effects of nanoparticles on humans, little is known about their effects on the respiratory system. To examine the protein expression in human lung microvascular endothelial cells (HMVEC-L) exposed to titanium dioxide (TiO2) nanoparticles, a common air pollutant. A proteomics approach using two-dimensional polyacrylamide gel electrophoresis (2D-PAGE) and matrix-assisted laser desorption/ionization time-of-flight/time-of-flight mass spectrometry (MALDI-TOF/TOF MS) was used to determine the differences in protein expression at 8 h and 24 h, following the treatment of HMVEC-L with 20-μM or 40-μM TiO2 nanoparticles. Human lung microvascular endothelial cells treated with 20-μM TiO2 nanoparticles showed alterations of 7 protein spots, including molecules related to calcium regulation, transport, cytoskeleton, and muscle contraction. The treatment of HMVEC-L with 40-μM TiO2 nanoparticles resulted in alterations of 4 protein spots, with molecular functions related to the cytoskeleton, myosin regulation, actin modulation, as well as guanosine diphosphate (GDP) and guanosine triphosphate (GTP) regulation. To validate these results, immunohistochemical staining and western blotting analyses were performed on lung tissues collected from mice exposed to TiO2 nanoparticles. Cofilin-1 and profilin-1 were expressed in the endothelium, epithelium and inflammatory cells, and decreased in lung tissues of TiO2 nanoparticle-exposed mice compared to sham-treated controls. These results suggest that some of the differentially expressed proteins may play important roles in airway diseases caused by TiO2 nanoparticle exposure.

1 January 2020 in Allergy, Asthma & Immunology Research
Verified
Journal Article
Open access
PDF file
PLPureun-Haneul Lee
Pureun-Haneul Lee
BKByeong-Gon Kim
Byeong-Gon Kim
MPMoo Kyun Park
Moo Kyun Park
JHJisu Hong
Jisu Hong
YLYun-Gi Lee
Yun-Gi Lee
AJAn-Soo Jang
An-Soo Jang
Lee PH, et al. Allergy Asthma Immunol Res. 2021 Mar;13(2):350-352. https://doi.org/10.4168/aair.2021.13.2.350